Login to Your Account



Structural GenomiX Enters Deal To Study Protein In Huntington's

By Aaron Lorenzo


Wednesday, December 11, 2002
Looking to advance the discovery and development of therapeutics, Structural GenomiX Inc. and the Hereditary Disease Foundation entered a collaboration to use SGX's structure-directed drug discovery technologies to investigate the structure of the protein responsible for Huntington's disease. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription